BioLineRx Ratios (2023-2025) | BLRX

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 78.77%83.37%83.37%48.17%86.67%76.32%80.33%
EBT Margin 1,505.71%-1,376.34%-1,716.63%-56.79%-68.38%-76.11%-67.57%-772.94%-666.78%-445.67%
EBIT Margin 1,405.71%-1,476.34%-1,816.63%-70.34%-107.05%-108.98%-37.67%-937.65%-757.57%-516.86%
EBITDA Margin 224.76%-169.18%-138.55%-10.15%-26.26%-28.65%-27.13%-555.29%-465.79%-331.62%
Operating Margin 1,405.71%-1,476.34%-1,816.63%-70.34%-107.05%-108.98%-37.67%-937.65%-757.57%-516.86%
Net Margin 1,505.71%-1,376.34%-1,716.63%-56.79%-68.38%-76.11%-67.57%-772.94%-666.78%-445.67%
FCF Margin 1,267.30%-1,182.80%489.92%-205.35%-209.57%-198.77%-73.33%-1,016.08%-58.22%-493.21%
Efficiency
Inventory Average 1.65M2.42M3.26M3.59M3.34M3.23M3.08M2.52M
Assets Average 63.79M55.90M58.39M57.76M58.10M58.67M45.82M41.21M43.39M41.54M
Invested Capital 2.56M3.08M3.08M3.15M3.68M10.66M9.82M4.48M4.68M4.48M4.48M
Asset Utilization Ratio 0.020.150.240.310.630.540.400.31
Leverage & Solvency
Interest Coverage Ratio -14.067.4214.7618.175.192.773.32-1.265.698.347.26
Debt Ratio 0.160.200.220.150.190.460.530.350.280.260.25
Times Interest Earned -14.067.4214.7618.175.192.773.32-1.265.698.347.26
Valuation
Enterprise Value -43.29M-33.30M-28.83M-42.99M-28.17M-40.06M-29.17M-19.56M-26.37M-28.16M-25.21M
Return Ratios
Return on Sales 15.06%-13.76%-17.17%-0.57%-0.68%-0.76%-0.68%-7.73%-6.67%-4.46%
Return on Capital Employed -3.18%-1.73%-1.51%-1.02%-0.67%-0.66%-0.52%-0.41%
Return on Assets -0.81%-0.72%-0.63%-0.49%-0.42%-0.42%-0.36%-0.33%